Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 18 announcements

Share price
₹839.30
Market cap
₹15,033 Cr
Revenue (annual)
₹4,078 Cr
Net profit (annual)
₹1,418 Cr
P/E (TTM)
13.1×Sector 50.4×
Promoter holding
49.42%+0.00% QoQ
FII holding
16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:33 IST BSE
Fund Raise

Natco Pharma Fund Raise of ₹1,279 Cr

Natco Pharma's board has approved a Rights Issue to raise ₹1,279.36 Crore. The company will issue 17,058,082 equity shares at ₹750 each in a 2:21 ratio.

Value
₹1,279 Cr
11:17 IST NSE
Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma's board approved a Rights Issue of 1,70,58,082 shares aggregating to ₹1,279.36 Crore. The issue is priced at ₹750 per share with a 2:21 ratio.

Value
₹1,279 Cr
17:56 IST BSE
Board Meeting Date

Natco Pharma Board Meeting Date

Natco Pharma will hold a board meeting on 25th September 2026 to finalise terms for its previously approved rights issue, including pricing and record date.

22:44 IST BSE
Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma has received in-principle approval from BSE and NSE for its upcoming Rights Issue of fully paid-up equity shares.